Cargando…
Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks
INTRODUCTION: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19. This study aimed to investigate Changes in the level of Antiphospholipid an...
Autores principales: | Haghighipour, Somayeh, Salesi, Mansour, Keikhaei, Fereshteh, Tarrahi, Mohammad J., Khani, Zahra, Salehi, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284197/ https://www.ncbi.nlm.nih.gov/pubmed/37351036 http://dx.doi.org/10.4103/ijpvm.ijpvm_377_21 |
Ejemplares similares
-
Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
por: Vanoverschelde, Laura, et al.
Publicado: (2019) -
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients
por: Trahtemberg, Uriel, et al.
Publicado: (2021) -
Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
por: Kang, H. J., et al.
Publicado: (1998) -
Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome
por: Zhang, Shulan, et al.
Publicado: (2015) -
Advances in the Research on Anticardiolipin Antibody
por: Wang, Dan, et al.
Publicado: (2019)